Pharmacy2U reports 350 per cent growth
Pharmacy2U, the UK’s largest NHS online pharmacy, has today reported a 350 per cent growth in patients since merging with Chemist Direct one year ago. The repeat prescription service dispensed over 200,000 items to patients last month alone – the highest level recorded since creating its state-of-the-art dispensing facility that uses machine learning robots to improve the speed and accuracy of its delivery under the supervision of a team of expert pharmacists.
The UK’s leading repeat prescription service was a founding partner of the NHS Electronic Prescription Service and registered over 25,000 new patients in August alone. 12 months on from the merger with Chemist Direct it is the largest and most efficient dispensing hub in the UK, opening the equivalent of seven new pharmacies each month and growing.
The technology-driven health service is led by Mark Livingstone, who disrupted the home entertainment industry as CEO of LOVEFiLM, now an Amazon company, and the food industry as a founding investor of Graze. His latest mission is disrupting healthcare and helping to modernise patient access to medication in partnership with the NHS by managing the repeat prescription process from request to delivery
People getting their prescriptions delivered to their door through Pharmacy2U have been found to save 3 hours and 39 minutes a month taking into account time spent in GP waiting rooms, travelling to pick up medicines and queuing. Patients were also found to save an average of £147 a year on transport and other costs associated with managing their repeat prescriptions by having their medicines delivered directly to their door.
The Leeds based company has established the UK’s most advanced pharmaceutical hub that can already dispense up to one million prescription items a month. Its use of technology is saving the NHS between 27 per cent and 44 per cent compared to the average bricks and mortar pharmacy, according to a recent analysis of the remuneration system of pharmacies in England.
Mark Livingstone, CEO of Pharmacy2U, comments: “Since merging we have invested heavily in our technological infrastructure and our state-of-the-art dispensing hub is already capable of distributing up to one million prescription items a month so there is still lots of room to grow. Technology has transformed industries from retail and entertainment to travel and leisure and it is now making a significant, and much-needed, mark on healthcare. We are on a mission to help modernise healthcare and improve patient outcome in partnership with the NHS by managing repeat prescriptions from request to delivery, which relieves both the time and stress put on GPs, represents better value to the NHS and improves patient medicine adherence.”
Pharmacy2U services include NHS repeat prescriptions, private prescriptions and an online doctor service which offers confidential consultations with registered GPs.
Business funding news
BGF welcomes successful exit of Brindley Healthcare
BGF has welcomed the successful acquisition of a 50% shareholding in Brindley Healthcare by French multinational Orpea, a leading European…
BGF to become cornerstone investor in Calnex Solutions’ IPO
BGF has today announced that it is investing in Calnex Solutions plc, an established provider of test and measurement solutions…